A Study to Evaluate the Safety, Tolerability, PK and PD of DA-1241 in Healthy Male Subjects and Subjects With T2DM

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This is a double‐blind, placebo‐controlled, multiple ascending dose study to evaluate the safety, tolerability, PK and PD of DA‐1241 in healthy male subjects and subjects with T2DM
Epistemonikos ID: 573b96171fe5cf0c3ace132206da9d8f87ba8e20
First added on: May 21, 2024